PF-Atlas › Клинические испытания › NCT06574581
ADSCs Therapy in Patients With CTD-ILD
ADSC01 · Фаза 1
ID реестра
NCT06574581
Фаза
Фаза 1
Статус
Набор идет
Препарат / вмешательство
ADSC01
Спонсор
China Medical University Hospital
Начало
2024-08-20
Набор участников
16
Центры
1
Об исследовании
Connective tissue disease (CTD), an autoimmune and inflammatory disease, usually accompanied by lung interstitial/alveolar inflammation and fibrosis (so called interstitial lung disease, ILD). The prevalence and mortality rate of CTD-ILD increase in recent several years. Although the use of corticosteroids and strong immunosuppressants can improve ILD in some patients with CTD, progressive lung fibrosis which needs lung transplantation and results in respiratory failure, even with mortality is observed. Currently, stem cell therapy is a breakthrough in the treatment of CTD-ILD, and the effective therapy with stem cells for patients with ILD have been reported.
Связанные материалы
Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT06574581 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.